Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Product number

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter Under evaluation Remove Under evaluation filter CMDh final position (3) Apply CMDh final position filter Procedure started (1) Apply Procedure started filter

Referral safety status

Yes Remove Yes filter

Referral type

Article 31 referrals Remove Article 31 referrals filter Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter Article 13 referrals Remove Article 13 referrals filter Article 30 referrals Remove Article 30 referrals filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 20 procedures (5) Apply Article 20 procedures filter Article 107i procedures (5) Apply Article 107i procedures filter Article 29(4) referrals (1) Apply Article 29(4) referrals filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (5) Apply PRAC-CHMP-EC filter PRAC-CMDh (1) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (5) Apply Centrally and nationally authorised products (mixed) filter Nationally authorised product(s) (6) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (2) Apply Risk minimisation measures filter Suspension (1) Apply Suspension filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring (2) Apply Additional monitoring filter Generic (2) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

74 results

Remove all filtersRemove all filters

Categories Human Remove Human filter

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter Opinion provided by Committee for Medicinal Products for Human Use Remove Opinion provided by Committee for Medicinal Products for Human Use filter Under evaluation Remove Under evaluation filter

Referral type Article 30 referrals Remove Article 30 referrals filter Article 13 referrals Remove Article 13 referrals filter Article 107 procedures (prior to July 2012) Remove Article 107 procedures (prior to July 2012) filter Article 36 referrals (prior to July 2012) Remove Article 36 referrals (prior to July 2012) filter Article 31 referrals Remove Article 31 referrals filter

Referral safety status Yes Remove Yes filter

Sort by

List item

Referral: Sibutramine

Sibutramine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 26/03/2001, Last updated: 13/12/2002
List item

Referral: Baxter dialysis solutions

Baxter dialysis solutions, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/10/2011, EC decision date: 16/12/2011, Last updated: 20/11/2013
List item

Referral: Agreal

veralipride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2007, EC decision date: 01/10/2007, Last updated: 07/01/2008
List item

Referral: Anorectics

amfepramome, clobenzorex, dexfenfluramine, fenbutrazate, fenfluramine, fenproporex, mazindol, mefenorex, norpseudoephedrine, phenmetrazine, phendimetrazine, phentermine and propylhexedrine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/1996, EC decision date: 09/12/1996, Last updated: 10/12/1996
List item

Referral: Antifibrinolytic medicines

aprotinin, aminocaproic acid, tranexamic acid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/06/2012, Last updated: 06/11/2013
List item

Referral: Aprotinin

aprotinin, associated names: Trasylol, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/11/2007, EC decision date: 15/02/2008, Last updated: 22/11/2007
List item

Referral: Benfluorex

benfluorex, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 14/06/2010, Last updated: 27/07/2011
List item

Referral: Bicalutamide 150 mg

bicalutamide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/05/2007, EC decision date: 03/09/2007, Last updated: 03/10/2007
List item

Referral: Bisphosphonates

alendronic acid, clodronic acid, etidronic acid, ibandronic acid, neridronic acid, pamidronic acid, risedronic acid, tiludronic acid, zoledronic acid, associated names: Actonel, Aredia, Bonefos, Didronel, Fosamax, Nerixia, Skelid, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/04/2011, EC decision date: 13/07/2011, Last updated: 28/10/2011
List item

Referral: Bufexamac

bufexamac, associated names: Parfenac, Bufal, Calmaderm, Fansamac, Mastu S, Parfenoide, Proctosan, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 27/07/2010, Last updated: 10/11/2011
List item

Referral: Buflomedil

buflomedil, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 17/11/2011, EC decision date: 13/02/2012, Last updated: 13/06/2012
List item

Referral: Calcitonin

calcitonin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 13/02/2013, Last updated: 19/07/2013
List item

Referral: Calcitonins

calcitonin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/11/2002, EC decision date: 12/06/2003, Last updated: 02/03/2004
List item

Referral: Carisoprodol

carisoprodol, associated names: Somadril, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 15/11/2007, EC decision date: 05/02/2008, Last updated: 16/11/2007
List item

Referral: Celecoxib

celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2005, EC decision date: 28/11/2005, Last updated: 06/12/2005
List item

Referral: Celecoxib

celecoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 21/11/2003, EC decision date: 29/04/2004, Last updated: 09/06/2004
List item

Referral: Chlormezanone

chlormezanone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/01/1997, EC decision date: 27/08/1997, Last updated: 22/09/1997
List item

Referral: Cisapride

cisapride, Article 31 referrals
Status: European Commission final decision, opinion/position date: 13/12/2001, EC decision date: 30/05/2002, Last updated: 29/10/2002
List item

Referral: Clobutinol

clobutinol, associated names: Silomat, Article 107 procedures (prior to July 2012)
Status: European Commission final decision, opinion/position date: 18/10/2007, EC decision date: 30/11/2007, Last updated: 19/10/2007
List item

Referral: Dexrazoxane

dexrazoxane, associated names: Cardioxane, Cyrdanax, Dexrazoxane Cyathus, Enaxozar, Procard, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 13/09/2011, Last updated: 16/01/2012
List item

Referral: Dextropropoxyphene

dextropropoxyphene, Article 31 referrals
Status: European Commission final decision, opinion/position date: 22/10/2009, EC decision date: 14/06/2010, Last updated: 07/04/2011
List item

Referral: Dienogest/ethinylestradiol-containing medicinal products indicated in acne

dienogest / ethinylestradiol, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 22/03/2017, Last updated: 24/03/2017
List item

Referral: Elidel

pimecrolimus, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/03/2006, Last updated: 29/08/2006
List item

Referral: Ergot-derived dopamine agonists

bromocriptine, cabergoline, dihydroergocryptine, lisuride and pergolide, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 26/06/2008
List item

Referral: Etoricoxib

etoricoxib, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, Last updated: 21/11/2008

Load more

74 results

Referral: Sibutramine

Referral: Baxter dialysis solutions

Referral: Agreal

Referral: Anorectics

Referral: Antifibrinolytic medicines

Referral: Aprotinin

Referral: Benfluorex

Referral: Bicalutamide 150 mg

Referral: Bisphosphonates

Referral: Bufexamac

Referral: Buflomedil

Referral: Calcitonin

Referral: Calcitonins

Referral: Carisoprodol

Referral: Celecoxib

Referral: Celecoxib

Referral: Chlormezanone

Referral: Cisapride

Referral: Clobutinol

Referral: Dexrazoxane

Referral: Dextropropoxyphene

Referral: Dienogest/ethinylestradiol-containing medicinal products indicated in acne

Referral: Elidel

Referral: Ergot-derived dopamine agonists

Referral: Etoricoxib